HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gennaro Ciliberto Selected Research

Stearoyl-CoA Desaturase

8/2021SCD1, autophagy and cancer: implications for therapy.
1/2020CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
12/2018Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.
10/2017Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gennaro Ciliberto Research Topics

Disease

137Neoplasms (Cancer)
04/2022 - 12/2002
38Melanoma (Melanoma, Malignant)
04/2022 - 04/2012
32Breast Neoplasms (Breast Cancer)
11/2021 - 03/2009
14COVID-19
06/2022 - 01/2020
10Prostatic Neoplasms (Prostate Cancer)
06/2022 - 12/2008
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2010
9Infections
10/2021 - 05/2005
7Triple Negative Breast Neoplasms
01/2022 - 03/2018
7Inflammation (Inflammations)
01/2021 - 06/2009
7Lung Neoplasms (Lung Cancer)
01/2020 - 09/2012
6Colonic Neoplasms (Colon Cancer)
11/2020 - 12/2008
6Carcinogenesis
01/2020 - 03/2013
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2006
5Hepatocellular Carcinoma (Hepatoma)
10/2016 - 01/2015
4Lymphoma (Lymphomas)
01/2022 - 08/2010
4Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 01/2013
4Neoplasm Metastasis (Metastasis)
10/2020 - 06/2009
4Malignant Pleural Effusion
01/2020 - 08/2010
4Kidney Neoplasms (Kidney Cancer)
07/2018 - 01/2016
4Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2017 - 08/2013
4Carcinoma (Carcinomatosis)
06/2009 - 07/2008
3Adenocarcinoma of Lung
12/2021 - 06/2013
3Genomic Instability
01/2020 - 01/2018
3Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 12/2016
3Disease Progression
09/2019 - 07/2008
3Abdominal Obesity
05/2017 - 01/2014
3Sarcoma (Soft Tissue Sarcoma)
01/2017 - 01/2016
3Urinary Bladder Neoplasms (Bladder Cancer)
11/2016 - 04/2010
3Renal Cell Carcinoma (Grawitz Tumor)
11/2016 - 01/2016
3Insulin Resistance
01/2014 - 03/2013
2Brain Neoplasms (Brain Tumor)
06/2022 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2021
2Hypertension (High Blood Pressure)
06/2021 - 10/2015
2Multiple Myeloma
01/2021 - 12/2002
2Obesity
11/2020 - 03/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 01/2009
2Adenocarcinoma
11/2019 - 01/2009

Drug/Important Bio-Agent (IBA)

33VaccinesIBA
06/2022 - 06/2005
27Proteins (Proteins, Gene)FDA Link
04/2022 - 02/2002
21DNA (Deoxyribonucleic Acid)IBA
04/2021 - 02/2002
20Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2008
20Pharmaceutical PreparationsIBA
01/2021 - 12/2008
20AntigensIBA
01/2020 - 11/2002
16AntibodiesIBA
01/2022 - 01/2006
15Biological ProductsIBA
01/2022 - 03/2009
14Cancer VaccinesIBA
02/2019 - 05/2006
13Immune Checkpoint InhibitorsIBA
01/2022 - 01/2014
11MicroRNAs (MicroRNA)IBA
01/2022 - 01/2016
11Monoclonal AntibodiesIBA
01/2022 - 05/2006
10CytokinesIBA
10/2021 - 01/2015
9Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2022 - 07/2013
8Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020 - 12/2008
7BNT162 VaccineIBA
06/2022 - 01/2021
7EpitopesIBA
02/2022 - 06/2009
6pertuzumabIBA
01/2021 - 01/2017
5Messenger RNA (mRNA)IBA
06/2022 - 06/2009
5EnzymesIBA
08/2021 - 08/2010
5Interleukin-6 (Interleukin 6)IBA
05/2021 - 12/2002
5Small Interfering RNA (siRNA)IBA
03/2021 - 06/2009
5LigandsIBA
09/2020 - 02/2011
5Peptides (Polypeptides)IBA
01/2020 - 01/2014
5IpilimumabIBA
01/2018 - 03/2013
4Ado-Trastuzumab EmtansineIBA
11/2021 - 01/2017
4Stearoyl-CoA DesaturaseIBA
08/2021 - 10/2017
4Phosphotransferases (Kinase)IBA
11/2020 - 05/2005
4Hormones (Hormone)IBA
01/2019 - 03/2013
4Phenobarbital (Luminal)FDA Link
01/2019 - 07/2010
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2017 - 12/2002
3Taxoids (Taxanes)IBA
09/2020 - 01/2019
3AnthracyclinesIBA
09/2020 - 01/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 05/2005
3Antineoplastic Agents (Antineoplastics)IBA
05/2020 - 09/2014
3Proto-Oncogene Proteins B-rafIBA
03/2020 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 04/2012
3Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 08/2013
3Endocrine DisruptorsIBA
11/2017 - 01/2017
3Insulin (Novolin)FDA Link
01/2017 - 03/2013
3Tyrosine Kinase InhibitorsIBA
12/2015 - 10/2012
3Carcinoembryonic AntigenIBA
02/2014 - 01/2006
2COVID-19 VaccinesIBA
06/2022 - 01/2021
2Indicators and Reagents (Reagents)IBA
04/2022 - 11/2020
2DNA VaccinesIBA
02/2022 - 03/2013
2InterferonsIBA
10/2021 - 12/2013
2Monounsaturated Fatty AcidsIBA
08/2021 - 10/2017
2eribulinFDA Link
01/2021 - 01/2019
2Epidermal Growth Factor (EGF)IBA
01/2021 - 02/2014
2Trastuzumab (Herceptin)FDA Link
12/2020 - 01/2019
2Valproic Acid (Depakote)FDA LinkGeneric
10/2020 - 04/2016
2LipidsIBA
10/2020 - 10/2016
2RNA (Ribonucleic Acid)IBA
11/2019 - 01/2015
2Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
11/2019 - 12/2017
2NeuregulinsIBA
09/2019 - 07/2013
2Estrogen ReceptorsIBA
09/2019 - 02/2015
2ChemokinesIBA
01/2019 - 04/2016

Therapy/Procedure

61Therapeutics
04/2022 - 10/2007
28Immunotherapy
01/2022 - 06/2009
15Drug Therapy (Chemotherapy)
08/2021 - 08/2013
6Precision Medicine
04/2021 - 11/2015
5Radiotherapy
01/2021 - 01/2014
2Neoadjuvant Therapy
05/2020 - 03/2018